Geneos Therapeutics

Geneos Therapeutics is a clinical-stage (Phase 2b) biotherapeutics company in Philadelphia, Pennsylvania developing DNA-based personalized immunotherapies for cancer (PICs). Its GT-EPIC neoantigen-targeting platform sequences a patient's tumor, identifies the targetable neoantigens, and encodes up to roughly 40 of them into a synthetic DNA plasmid drug product delivered intradermally alongside a plasmid-encoded IL-12 adjuvant and CELLECTRA electroporation. Geneos was spun out of Inovio Pharmaceuticals and licenses that immunotherapy platform exclusively; it has run clinical work in hepatocellular carcinoma (HCC) and glioblastoma (GBM) and is advancing toward a Phase 2b HCC trial. Geneos is a therapeutics developer, not a software vendor: it publishes no public API, SDK, developer portal or machine-readable contract of any kind.

Geneos Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Therapeutics, Immunotherapy, and Oncology.

Geneos Therapeutics’ developer surface includes support, engineering blog, and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub

9.6/100 minimal Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0

0 APIs

CompanyBiotechnologyTherapeuticsImmunotherapyOncologyPrecision MedicineClinical StageLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0

Composite quality — 9.6/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 1.1 / 17

Commercial Clarity 1.8 / 17

Operational Transparency 0.0 / 11

Governance 0.0 / 10

Discoverability 4.9 / 9

Regulatory Posture 1.9 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/geneos-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 2

The organization behind the API

Website

Website

Blog

Blog

Source (apis.yml)

aid: geneos-therapeutics
name: Geneos Therapeutics
description: 'Geneos Therapeutics is a clinical-stage (Phase 2b) biotherapeutics company in Philadelphia, Pennsylvania developing
  DNA-based personalized immunotherapies for cancer (PICs). Its GT-EPIC neoantigen-targeting platform sequences a patient''s
  tumor, identifies the targetable neoantigens, and encodes up to roughly 40 of them into a synthetic DNA plasmid drug product
  delivered intradermally alongside a plasmid-encoded IL-12 adjuvant and CELLECTRA electroporation. Geneos was spun out of
  Inovio Pharmaceuticals and licenses that immunotherapy platform exclusively; it has run clinical work in hepatocellular
  carcinoma (HCC) and glioblastoma (GBM) and is advancing toward a Phase 2b HCC trial. Geneos is a therapeutics developer,
  not a software vendor: it publishes no public API, SDK, developer portal or machine-readable contract of any kind.'
image: https://www.geneostx.com/wp-content/uploads/2021/09/logo-color.svg
url: https://raw.githubusercontent.com/api-evangelist/geneos-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-16'
modified: '2026-08-16'
tags:
- Company
- Biotechnology
- Therapeutics
- Immunotherapy
- Oncology
- Precision Medicine
- Clinical Stage
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.geneostx.com/
- type: PrivacyPolicy
  url: https://www.geneostx.com/privacy-policy/
- type: Support
  url: https://www.geneostx.com/contact/
- type: Blog
  url: https://www.geneostx.com/press-releases/
- type: DomainSecurity
  url: security/geneos-therapeutics-domain-security.yml
- type: LLMsTxt
  url: llms/geneos-therapeutics-llms.txt
x-enrichment:
  date: '2026-08-16'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Geneos Therapeutics is a Phase 2b clinical-stage cancer-immunotherapy developer whose product is a DNA plasmid drug,
    not software; its six-page WordPress corporate site has no developer, API or technology-integration section at all, api/docs/developer(s)/portal
    subdomains of geneostx.com do not resolve (NXDOMAIN), there is no GitHub organization and no package in npm or PyPI, and
    every contract-discovery and /.well-known/ path probed returned 404.
  evidence:
  - url: https://www.geneostx.com/openapi.json
    status: 404
  - url: https://www.geneostx.com/.well-known/agent-card.json
    status: 404
  - url: https://www.geneostx.com/api
    status: 404
  - url: https://api.github.com/orgs/geneostx
    status: 404
  - url: https://www.geneostx.com/sitemap_index.xml
    status: 200
  checked: '2026-08-16'